Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 230-813-8 | CAS number: 7328-22-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / micronucleus study
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- migrated information: read-across based on grouping of substances (category approach)
- Adequacy of study:
- key study
- Study period:
- 07.09.2011-10.09.2012
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study, GLP
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 012
- Report Date:
- 2012
Materials and methods
Test guideline
- Qualifier:
- according to
- Guideline:
- other: Micronucleus assay in vitro in Human Lymphocytes, OECD 487, adopted July 22, 2010
- Deviations:
- no
- GLP compliance:
- yes (incl. certificate)
- Remarks:
- certificate dated 30 March 2009
- Type of assay:
- in vitro mammalian cell micronucleus test
Test material
Reference
- Name:
- Unnamed
- Type:
- Constituent
- Test material form:
- other: liquid
- Details on test material:
- - Name of test material (as cited in study report): Ethyltriglycol methacrylate
Method
- Target gene:
- n/a (micronucleus test)
Species / strain
- Species / strain / cell type:
- lymphocytes: human, healthy donors not receiving medication
- Details on mammalian cell type (if applicable):
- Blood samples were obtained from healthy, non-smoking donors not receiving medication. For this study, blood was collected from a female donor (22 years old) for the first experiment, from a 34 year-old female donor for Experiment IIA and from a 32 year-old female donor for Experiment IIB. All donors had a previously established low incidence of micronuclei in their peripheral blood lymphocytes.
Blood samples were drawn by venous puncture and collected in heparinized tubes by Dr. V. Theodor (64380 Rossdorf, Germany). The tubes were
sent to Harlan CCR to initiate cell cultures within 24 hrs after blood collection. If necessary, the blood was stored before use at 4 °C.
- Type and identity of media: Dulbecco's modified eagle medium/Ham's F12 medium, mixture 1:1, supplemented with 200 mM GlutaMax, penicillin/streptomycin (100 U/mL/100 µg/mL), phytohemagglutinin (PHA, 3 µg/mL), 10 % FBS (fetal bovine serum), 10 mM HEPES, heparin (125 U.S.P.-U/mL) - Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- rat liver S9 mix
- Test concentrations with justification for top dose:
- 16.1 -2486.0 µg/ml (pre-test and main experiment)
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: deionised water
- Justification for choice of solvent/vehicle: The final concentration of deionised water in the culture medium was 10 % (v/v). The solvent was chosen due to its solubility properties and its relative non-toxicity to the cell cultures.
Controls
- Untreated negative controls:
- yes
- Remarks:
- culture medium
- Negative solvent / vehicle controls:
- yes
- Remarks:
- culture medium with 10 % deionised water
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- mitomycin C
- other: demecloclin
- Remarks:
- without metabolic activation
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
Exposure duration:
Experiment I:
4 hours treatment with and without metabolic activation
Experiment II A:
4 hours treatment with metabolic activation
Experiment II B:
20 hours without metabolic activation
SPINDLE INHIBITOR (cytogenetic assays): 4 mg/L cytochalasin B
STAIN (for cytogenetic assays): Giemsa
NUMBER OF REPLICATIONS: 2 per experiment
NUMBER OF CELLS EVALUATED: 1000 binucleate cells per culture were scored for cytogenetic damage
DETERMINATION OF CYTOTOXICITY
Method: CBPI (Cytokinesis-block proliferation index) was determined in approximately 500 cells per culture and cytotoxicity is expressed as %
cytostasis
- Evaluation criteria:
- The micronucleus assay is considered acceptable if it meets the following criteria:
- The number of micronuclei found in the negative and solvent controls falls within the range of the laboratory historical control data
- The positive control substances should produce significant increases in the number of cells with micronuclei.
A test item can be classified as non-mutagenic if:
- the number of micronucleated cells in all evaluated dose groups is in the range of the laboratory historical control data and/or
-no statistically significant or concentration-related increase in the number of micronucleated cells is observed.
A test item can be classified as mutagenic if:
- the number of micronucleated cells is not in the range of the historical laboratory control data and
- either a concentration-related increase of micronucleated cells in three test groups or a statistically significant increase of the number of micronucleated cells is observed. - Statistics:
- Chi square test
Results and discussion
Test results
- Species / strain:
- lymphocytes: primary human
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: 7.3 – 7.5 for solvent control as well as test item in all experiments
- Effects of osmolality: 264-289 for solvent control, 280 - 301 for test item in all experiments -> no relevant influence
- Precipitation: No precipitation of the test item was observed up to highest concentration tested
RANGE-FINDING/SCREENING STUDIES:
- Pre-test for cytotoxicity: concentrations 161, 28.3, 49.5, 86.6, 151.5, 265.1, 463.9, 811.8, 1420.6 and 2486.0 µg/ml with and without metabolic activation
Using a reduced CBPI as an indicator for toxicity in Experiment I, no cytotoxic effects were observed after 4 hrs treatment in the absence and presence of S9 mix.
COMPARISON WITH HISTORICAL CONTROL DATA:
The micronucleus rates of the cells after treatment with the test item (0.05 - 0.95 % micronucleated cells) were within the range of the solvent control values (0.35 -1.05 % micronucleated cells) and within the range of the laboratory historical control data
ADDITIONAL INFORMATION ON CYTOTOXICITY:
- In Experiment I in the absence and presence of S9 mix and in Experiment IIA in the presence of S9 mix no cytotoxicity was observed up to the highest applied concentration.
- In Experiment IIA in the absence of S9 mix concentrations showing cytotoxic effects were not evaluable for cytogenetic damage
- In Experiment IIB in the absence of S9 mix cytotoxicity was observed at the highest evaluated concentration. - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
Exp. | Test item concentration [mg/L] | Proliferation index CBPI | Cytostasis [%] | Micronucleated cells [%] |
Exposure period 4 hrs without S9 mix | ||||
I | Negative control | 1.84 |
| 0.35 |
| Solvent control | 1.95 |
| 0.55 |
| Positive control | 1.80 | 5.1 | 3.85S |
| 811.8 | 1.84 | 11.5 | 0.35 |
| 1420.6 | 1.86 | 9.5 | 0.35 |
| 2486.0 | 1.90 | 5.8 | 0.35 |
Exposure period 20 hrs without S9 mix | ||||
IIA | Negative control | 1.97 |
| 0.60 |
| Solvent control | 1.88 |
| 0.60 |
| Positive control | 1.58 | 40.1 | 3.70S |
| 265.1 | 1.75 | 14.9 | 0.25 |
| 463.9 | 1.71 | 19.2 | 0.55 |
| 811.8 | 1.67 | 24.3 | 0.45 |
Exposure period 20 hrs without S9 mix | ||||
IIB | Negative control | 1.90 |
| 0.20 |
| Solvent control | 1.89 |
| 0.35 |
| Positive control | 1.38 | 57.6 | 3.25S |
| 300.0 | 1.83 | 6.2 | 0.15 |
| 1000.0 | 1.65 | 26.5 | 0.20 |
| 2000.0 | 1.45 | 49.3 | 0.15 |
* For the positive control groups, the relative values are related to the negative controls;
for the test item treatment groups the values are related to the solvent controls
** The number of micronucleated cells was determined in a sample of 2000 binucleated cells
SThe number of micronucleated cells is statistically significantly higher than corresponding control
values
1Deionised water 10.0 % (v/v)
2MMC 2.0Mg/mL
3Demecolcin 75.0 ng/mL
4Demecolcin 125.0 ng/mL
Exp. | Test item concentration [mg/L] | Proliferation index CBPI | Cytostasis [%] | Micronucleated cells [%] |
Exposure period 4 hrs with S9 mix | ||||
I | Negative control | 1.86 |
| 0.40 |
| Solvent control | 1.96 |
| 0.40 |
| Positive control | 152 | 39.4 | 5.70S |
| 811.8 | 1.91 | 5.1 | 0.05 |
| 1420.6 | 1.85 | 11.1 | 0.20 |
| 2486.0 | 1.93 | 3.2 | 0.60 |
Exposure period 4 hrs with S9 mix | ||||
IIA | Negative control | 1.83 |
| 0.55 |
| Solvent control | 1.87 |
| 1.05 |
| Positive control | 1.88 | n.c. | 5.55S |
| 811.8 | 1.86 | 0.9 | 0.95 |
| 1420.6 | 1.79 | 10.0 | 0.55 |
| 2486.0 | 1.77 | 11.7 | 0.70 |
* For the positive control groups, the relative values are related to the negative controls;
for the test item treatment groups the values are related to the solvent controls
** The number of micronucleated cells was determined in a sample of 2000 binucleated cells
n.c. Not calculated as the CBPI is equal or higher than the solvent control value
SThe number of micronucleated cells is statistically significantly higher than corresponding control
values
1Deionised water 10.0 % (v/v)
2CPA 10.0Mg/mL
3CPA 7.5Mg/mL
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative
Ethyltriglycol methacrylate is considered to be non-mutagenic in this in vitro micronucleus test, when tested up to cytotoxic or to the highest
required/evaluable concentration. - Executive summary:
In a mammalian cell micronucleus assay according to OECD guideline 487 (adopted July 22, 2010), primary human lymphocyte cultures were exposed to Ethytriglycol methacrylate (98.95%) in deionised water with and without metabolic activation (S9 mix).
The following concentrations were evaluated (dose calculations adjusted to purity):
Experiment I:
4 h treatment without metabolic activation: 16.1 -2486 µg/ml
4 h treatment with metabolic activation: 16.1 -2486 µg/ml
Experiment IIA:
20 h treatment without metabolic activation: 49.5 – 2486 µg/mL
4 h treatment with metabolic activation: : 151.5 – 2486 µg/mL
Experiment IIB:
20 h treatment without metabolic activation: 75 – 2400 µg/mL
Ethytriglycol methacrylate was tested up to cytotoxic or the guideline limit concentration of 10 mM (corresponding to 2486.0 mg/mL). Cytotoxic effects were observed after 4 h treatment with2486 µg/ml in the absence of S9 mix; no cytotoxicity was observed in the presence of S9 mix up to 2486 µg/ml
.
In the absence and presence of S9 mix no biologically relevant increase in the number of cells carrying micronuclei was observed after treatment with the test item.
The micronucleus rates of the cells after treatment with the test item (0.05 - 0.95 %
micronucleated cells) were within the range of the solvent control values (0.35 -1.05 %
micronucleated cells) and within the range of the laboratory historical control data.
Positive controls induced the appropriate response.
Ethyltriglycol methacrylate did not induce micronuclei in human lymphocytes in vitro, when
tested up to cytotoxic or the highest required/evaluable concentration. Therefore, Ethytriglycol methacrylate is considered to be non-clastogenic in this in vitro micronucleus test, when tested up to cytotoxic or the highest evaluable concentration.
NOTE: Any of data in this dataset are disseminated by the European Union on a right-to-know basis and this is not a publication in the same sense as a book or an article in a journal. The right of ownership in any part of this information is reserved by the data owner(s). The use of this information for any other, e.g. commercial purpose is strictly reserved to the data owners and those persons or legal entities having paid the respective access fee for the intended purpose.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

Route: .live2